December 5, 2019 – December 5, 2019 – The $1M award will support Dr. Pugh’s development work towards advancing a blood-based diagnostic for early cancer detection, in collaboration with Dr. Raymond Kim of the Princess Margaret Cancer Centre.
Read More from FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection
November 8, 2019 – November 8, 2019 – Titled “Ontario First in the innovation economy: impacts of a $1B USD public-private-partnership (PPP) on Canadian healthcare commercialization”, the panel seeks to highlight the outcomes and key lessons from this unprecedented partnership.
November 6, 2019 – November 6, 2019 – Scaling FACIT’s impact requires new partners and expanded expertise in the management of investments and equity markets. To that end, FACIT has recruited two seasoned executives through its Executive-in-Residence (EIR) Program.
October 30, 2019 – October 30, 2019 – Cellular Analytics is founded upon a proprietary microfluidic platform that enables molecular characterization of cancer at the level of single circulating tumour cells.
Read More from FACIT and University of Toronto launch precision medicine company: Cellular Analytics
October 24, 2019 – October 24, 2019 – New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology.
September 26, 2019 – September 26, 2019 – FACIT announces investments in Xpan Inc. and innovations from OICR and the University of Toronto
August 8, 2019 – August 8, 2019 – New collaboration will develop targeted next generation sequencing (NGS) assays and software to improve cancer management
June 3, 2019 – June 3, 2019 – FACIT’s network of industry partners and investors are becoming increasingly aware of the top-tier quality of Ontario’s innovations, which has been integral in attracting the $750M follow-on investment.
Read More from FACIT portfolio reports $750M follow-on financing
April 8, 2019 – April 8, 2019 – FACIT is pleased to announce recent successes in its mission to help bridge the capital gap often experienced by early-stage entrepreneurs.
April 2, 2019 – April 2, 2019 – Ontario First investor FACIT congratulates portfolio company Fusion Pharmaceuticals, a clinical-stage biotech developing novel targeted alpha radiotherapies
Read More from FACIT Features: Fusion Pharma completes $105M Series B financing